Condition: Polycystic Ovary Syndrome
Intervention: Drug: Metformin
Sponsor: University of Michigan
Recruiting - verified April 2008
By Cancer
3917 items (3917 unread) in 83 feeds
Click on blue folders to expand
Adrenal Gland Cancer
(428)
Ampulla Of Vater
(26)
Anal Cancer
(266)
Angiosarcoma
(67)
Appendix Cancer
(33)
Bile Duct Cancer
(518)
Brain & CNS
(746)
Carcinoid
(161)
Endocrine/Neuroendocrine
(254)
Gall Bladder Cancer
(86)
General
(108)
Hemangioendothelioma
(28)
HemeOnc
(439)
Hepatoblastoma
(59)
Pancreas
(48)
Phyllodes
(12)
Rhabdomyosarcoma
(212)
Sarcoma
(285)
Trial - Brain Tumor (50 unread)
-
Study of Brain Function in Women With Insulin Resistant Polycystic Ovary Syndrome
Posted: April 30th, 2008, 10:00am EDT
-
Study of Aminolevulinic Acid to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain
Posted: April 30th, 2008, 10:00am EDT
Condition: Malignant Glial Tumors of Brain
Intervention: Drug: Aminolevulinic Acid
Sponsor: Advocate Hospital System
Recruiting - verified April 2008 -
Temozolomide, Carmustine, O6-Benzylguanine, Radiation Therapy, and an Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Posted: April 29th, 2008, 10:00am EDT
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: O6-benzylguanine; Drug: carmustine; Drug: temozolomide; Procedure: autologous hematopoietic stem cell transplantation; Procedure: chemosensitization/potentiation therapy; Procedure: in vitro-treated peripheral blood stem cell transplantation; Procedure: oral chemotherapy; Procedure: parenteral chemotherapy; Procedure: radiation therapy
Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI)
Not yet recruiting - verified April 2008 -
Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis
Posted: April 29th, 2008, 10:00am EDT
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: Raloxifene HCL; Drug: Raloxifene HCL; Drug: Placebo
Sponsor: Eli Lilly and Company
Completed - verified April 2008 -
NORVIT and WENBIT - Long-Term Follow-up
Posted: April 29th, 2008, 10:00am EDT
Conditions: Cancer; Myocardial Infarction; Cerebrovascular Stroke
Intervention:
Sponsors: Haukeland University Hospital; University of Tromso; Norwegian Foundation for Health and Rehabilitation
Active, not recruiting - verified April 2008 -
Tandutinib and Bevacizumab in Treating Patients With Recurrent High-Grade Glioma
Posted: April 25th, 2008, 10:00am EDT
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: bevacizumab; Drug: tandutinib; Procedure: antiangiogenesis therapy; Procedure: monoclonal antibody therapy; Procedure: protein tyrosine kinase inhibitor therapy; Procedure: quality-of-life assessment
Sponsor: National Cancer Institute (NCI)
Recruiting - verified May 2008 -
Study to Examine Sleep and Fatigue in Pediatric Brain Tumor Patients Hospitalized for High Dose Chemotherapy
Posted: April 23rd, 2008, 10:00am EDT
Conditions: Sleep; Fatigue
Interventions: Other: Sleep Environment Intervention; Other: Normal Hospital Environment
Sponsor: St. Jude Children's Research Hospital
Recruiting - verified April 2008 -
Genetic Differences in Limbic Activation Associated With Nicotine Withdrawal
Posted: April 21st, 2008, 10:00am EDT
Condition: Smoking
Intervention: Other: Functional Magnetic Resonance Imaging (fMRI)
Sponsors: M.D. Anderson Cancer Center; National Institutes of Health (NIH)
Recruiting - verified April 2008 -
Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Posted: April 18th, 2008, 10:00am EDT
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: cediranib; Drug: temozolomide; Procedure: adjuvant therapy; Procedure: antiangiogenesis therapy; Procedure: diffusion tensor imaging; Procedure: diffusion-weighted magnetic resonance imaging; Procedure: dynamic contrast-enhanced magnetic resonance imaging; Procedure: immunoenzyme technique; Procedure: immunohistochemistry staining method; Procedure: intensity-modulated radiation therapy; Procedure: laboratory biomarker analysis; Procedure: oral chemotherapy; Procedure: protein tyrosine kinase inhibitor therapy; Procedure: proteomic profiling
Sponsors: Massachusetts General Hospital; National Cancer Institute (NCI)
Recruiting - verified May 2008 -
Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer
Posted: April 17th, 2008, 10:00am EDT
Conditions: Non-Small Cell Lung Cancer; Brain Metastases
Intervention: Drug: erlotinib
Sponsor: Guangdong Provincial People's Hospital
Active, not recruiting - verified April 2008 -
Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG-2402
Posted: April 15th, 2008, 10:00am EDT
Conditions: Breast Cancer; Cognitive/Functional Effects; Fatigue; Psychosocial Effects/Treatment; Sleep Disorders
Interventions: Procedure: assessment of therapy complications; Procedure: cognitive assessment; Procedure: fatigue assessment and management; Procedure: psychosocial assessment and care
Sponsors: International Breast Cancer Study Group; National Cancer Institute (NCI); ANZ Breast Cancer Trials Group; Cancer and Leukemia Group B
Recruiting - verified April 2008 -
Ferumoxytol and Gadolinium Magnetic Resonance Imaging (MRI) at 3T and 7T in Patients With Malignant Brain Tumors
Posted: April 10th, 2008, 10:00am EDT
Condition: Brain Neoplasms
Intervention: Drug: Ferumoxytol
Sponsors: Oregon Health and Science University; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified November 2007 -
Imaging of Intravenous (IV) Combidex to Brain, Intra-Cerebral Tumors and in Central Nervous System (CNS) Inflammation
Posted: April 10th, 2008, 10:00am EDT
Condition: Brain Neoplasms
Intervention: Drug: Ferumoxtran-10 (Combidex)
Sponsors: Oregon Health and Science University; National Institutes of Health (NIH); National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2008 -
Magnetic Resonance (MR) Imaging Study Using Ferumoxytol to Assess Early Tumor Response in Patients With Glioblastoma Multiforme
Posted: April 10th, 2008, 10:00am EDT
Condition: Diagnostic Imaging
Intervention: Drug: Ferumoxytol
Sponsors: Oregon Health and Science University; National Cancer Institute (NCI)
Recruiting - verified April 2008 -
Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System
Posted: April 3rd, 2008, 10:00am EDT
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: carboplatin; Drug: cisplatin; Drug: cyclophosphamide; Drug: etoposide; Drug: etoposide phosphate; Drug: filgrastim; Drug: methotrexate; Drug: thiotepa; Drug: vincristine; Procedure: 3-dimensional conformal radiation therapy; Procedure: autologous hematopoietic stem cell transplantation; Procedure: hematologic toxicity attenuation; Procedure: hematopoietic stem cell mobilization; Procedure: high-dose chemotherapy; Procedure: immunohistochemistry staining method; Procedure: mutation analysis; Procedure: parenteral chemotherapy; Procedure: peripheral blood stem cell transplantation
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified May 2008 -
Examining the Long-Term Risks of Oophorectomy
Posted: April 3rd, 2008, 10:00am EDT
Conditions: Coronary Heart Disease; Stroke; Breast Cancer; Ovarian Cancer; Cancer; Hip Fracture; Death
Intervention:
Sponsors: Parker, William H., M.D.; Ethicon, Inc.
Completed - verified April 2008 -
Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma
Posted: April 1st, 2008, 10:00am EDT
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: aflibercept; Drug: temozolomide; Procedure: DNA methylation analysis; Procedure: adjuvant therapy; Procedure: antiangiogenesis therapy; Procedure: laboratory biomarker analysis; Procedure: oral chemotherapy; Procedure: pharmacological study; Procedure: polymerase chain reaction; Procedure: radiation therapy; Procedure: targeted fusion protein therapy
Sponsors: North American Brain Tumor Consortium; National Cancer Institute (NCI)
Not yet recruiting - verified March 2008 -
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy in Cancer Patients
Posted: March 28th, 2008, 10:00am EDT
Condition: Brain Metastases
Interventions: Drug: ABT-888; Radiation: Whole Brain Radiation
Sponsor: Abbott
Not yet recruiting - verified March 2008 -
Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis
Posted: March 26th, 2008, 10:00am EDT
Condition: Secondary Progressive Multiple Sclerosis
Interventions: Drug: Simvastatin; Drug: Placebo
Sponsor: Imperial College London
Recruiting - verified April 2008 -
Freiburg ZNS-NHL Study
Posted: March 26th, 2008, 10:00am EDT
Condition: Primary Non Hodgkin Lymphoma of the Central Nervous System
Interventions: Drug: methotrexate; Drug: Rituximab; Drug: Cytarabine; Drug: Thiotepa; Drug: Carmustin
Sponsors: University Hospital Freiburg; University Hospital Tuebingen
Recruiting - verified March 2008 -
Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Posted: March 25th, 2008, 10:00am EDT
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: PEP-3-KLH conjugate vaccine; Drug: sargramostim; Drug: temozolomide; Procedure: adjuvant therapy; Procedure: biopsy; Procedure: fluorescence activated cell sorting; Procedure: immunoenzyme technique; Procedure: immunologic technique; Procedure: immunopotentiation therapy; Procedure: non-specific immune-modulator therapy; Procedure: non-tumor cell-derivative vaccine therapy; Procedure: oral chemotherapy; Procedure: radiation therapy
Sponsors: Duke University; National Cancer Institute (NCI)
Recruiting - verified May 2008 -
Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas
Posted: March 25th, 2008, 10:00am EDT
Conditions: Growth Hormone Deficiency; Pituitary Tumor
Intervention:
Sponsors: Columbia University; EMD Serono; Genentech
Recruiting - verified March 2008 -
Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme
Posted: March 21st, 2008, 10:00am EDT
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: bortezomib; Drug: vorinostat; Procedure: enzyme inhibitor therapy; Procedure: gene expression analysis; Procedure: gene expression profiling; Procedure: immunohistochemistry staining method; Procedure: laboratory biomarker analysis; Procedure: therapeutic conventional surgery
Sponsors: North Central Cancer Treatment Group; National Cancer Institute (NCI)
Not yet recruiting - verified May 2008 -
Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients
Posted: March 21st, 2008, 10:00am EDT
Condition: Acromegaly
Interventions: Drug: C2L-OCT-01 PR, 10 or 20 mg; Drug: C2L-OCT-01 PR, 20 mg
Sponsors: Mallinckrodt; Ambrilia Biopharma, Inc.
Recruiting - verified April 2008 -
Change in Quality of Life After Addition of Weekly 40 mg Pegvisomant/Placebo in Controlled Acromegalic Patients
Posted: March 21st, 2008, 10:00am EDT
Conditions: Quality of Life; Acromegaly
Intervention: Drug: Pegvisomant
Sponsor: Erasmus Medical Center
Completed - verified March 2008 -
Positron Emission Tomography-Computed Tomography (PET-CT) High-Grade Glioma
Posted: March 20th, 2008, 10:00am EDT
Condition: Cerebral Astrocytoma, High Grade
Intervention: Other: imaging (dynamic PET-CT scan)
Sponsors: Maastricht Radiation Oncology; Maastricht University
Not yet recruiting - verified March 2008 -
Randomized Multicentric Phase II Study of Prolonged Adjuvant Temozolomide or "Stop and Go" in Glioblastoma Patients: The PATSGO Study
Posted: March 20th, 2008, 10:00am EDT
Condition: Glioblastoma
Interventions: Drug: Temozolomide; Drug: Temozolomide
Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Recruiting - verified March 2008 -
Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Gliobl
Posted: March 20th, 2008, 10:00am EDT
Conditions: Glioblastoma Multiforme; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma
Intervention: Other: MRS Spectroscopy
Sponsors: Weill Medical College of Cornell University; MGI PHARMA, Inc.
Recruiting - verified June 2007 -
Radiation Therapy to the Head in Preventing Brain Metastases in Women Receiving Trastuzumab and Chemotherapy for Metastatic or Locally Advanced Breast Cancer
Posted: March 19th, 2008, 10:00am EDT
Condition: Breast Cancer
Interventions: Drug: trastuzumab; Procedure: chemotherapy; Procedure: monoclonal antibody therapy; Procedure: radiation therapy
Sponsor: Anglo Celtic Cooperative Oncology Group
Recruiting - verified April 2008 -
Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Posted: March 19th, 2008, 10:00am EDT
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: cytomegalovirus pp65-specific cytotoxic T lymphocytes; Drug: temozolomide; Drug: tetanus toxoid; Drug: therapeutic autologous dendritic cells; Drug: therapeutic autologous lymphocytes; Procedure: adjuvant therapy; Procedure: adoptive immunotherapy; Procedure: biopsy; Procedure: imaging technique; Procedure: immunoenzyme technique; Procedure: immunohistochemistry staining method; Procedure: immunologic technique; Procedure: non-specific immune-modulator therapy; Procedure: non-tumor cell-derivative vaccine therapy; Procedure: peripheral blood lymphocyte therapy; Procedure: polymerase chain reaction; Procedure: quality-of-life assessment; Procedure: radiation therapy; Procedure: reverse transcriptase-polymerase chain reaction; Procedure: systemic chemotherapy
Sponsors: Duke University; National Cancer Institute (NCI)
Recruiting - verified March 2008 -
Busulfan, Melphalan, Topotecan, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor
Posted: March 18th, 2008, 10:00am EDT
Conditions: Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Kidney Cancer; Neuroblastoma; Ovarian Cancer; Sarcoma; Testicular Germ Cell Tumor; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: busulfan; Drug: filgrastim; Drug: melphalan; Drug: topotecan hydrochloride; Procedure: autologous bone marrow transplantation; Procedure: autologous hematopoietic stem cell transplantation; Procedure: hematopoietic stem cell mobilization; Procedure: high-dose chemotherapy; Procedure: pharmacological study
Sponsors: Beckman Research Institute; National Cancer Institute (NCI)
Recruiting - verified March 2008 -
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
Posted: March 14th, 2008, 10:00am EDT
Condition: Cancer
Interventions: Drug: indinavir sulfate; Drug: ritonavir; Procedure: antiangiogenesis therapy; Procedure: drug modulation therapy; Procedure: enzyme inhibitor therapy; Procedure: radiation therapy; Procedure: radiosensitization
Sponsor: Oncology Institute of Southern Switzerland - Lugano
Recruiting - verified March 2008 -
Use of the Atkins Diet for Children With Sturge Weber Syndrome
Posted: March 14th, 2008, 10:00am EDT
Conditions: Epilepsy; Sturge Weber Syndrome
Intervention: Dietary Supplement: modified Atkins diet
Sponsors: Johns Hopkins University; Vascular Birthmarks Foundation
Recruiting - verified March 2008 -
Combination of Sorafenib and Radiation for Brain Metastases and Primary Brain Tumors
Posted: March 13th, 2008, 10:00am EDT
Conditions: Brain Metastases; Primary Brain Tumors
Interventions: Drug: sorafenib and radiotherapy; Drug: sorafenib, radiotherapy, and temozolomide
Sponsors: Thomas Jefferson University; Bayer
Recruiting - verified March 2008 -
Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men Receiving Glucocorticoids for Newly Diagnosed High-Grade Glioma
Posted: March 6th, 2008, 10:00am EST
Conditions: Brain and Central Nervous System Tumors; Musculoskeletal Complications
Interventions: Drug: testosterone gel; Procedure: androgen therapy; Procedure: management of therapy complications; Procedure: musculoskeletal complications management; Procedure: questionnaire administration
Sponsors: Sidney Kimmel Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - verified March 2008 -
Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors
Posted: March 5th, 2008, 10:00am EST
Conditions: Brain and Central Nervous System Tumors; Seizure
Interventions: Drug: levetiracetam; Drug: pregabalin; Procedure: anticonvulsant therapy
Sponsor: Centre Hospitalier Universitaire Vaudois
Recruiting - verified March 2008 -
A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors
Posted: March 5th, 2008, 10:00am EST
Condition: Childhood Cancer
Interventions: Drug: Adv-tk; Drug: Valacyclovir; Radiation: Radiotherapy
Sponsors: Dana-Farber Cancer Institute; Children's Hospital Boston; Advantagene, Inc.
Not yet recruiting - verified March 2008 -
A Pilot Study of 18F-FLT in Pediatric Patients With CNS Tumors
Posted: March 5th, 2008, 10:00am EST
Condition: Tumors of the Central Nervous System
Intervention: Other: [18F]-Fluorothymidine
Sponsors: Dana-Farber Cancer Institute; Children's Hospital Boston
Recruiting - verified April 2008 -
High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Germ Cell Tumors
Posted: February 29th, 2008, 10:00am EST
Conditions: Brain and Central Nervous System Tumors; Extragonadal Germ Cell Tumor; Ovarian Cancer; Teratoma; Testicular Germ Cell Tumor
Interventions: Drug: carboplatin; Drug: cyclophosphamide; Drug: etoposide; Drug: filgrastim; Drug: ifosfamide; Drug: paclitaxel; Procedure: autologous hematopoietic stem cell transplantation; Procedure: hematologic toxicity attenuation; Procedure: hematopoietic stem cell mobilization; Procedure: high-dose chemotherapy; Procedure: peripheral blood stem cell transplantation; Procedure: systemic chemotherapy
Sponsors: Beckman Research Institute; National Cancer Institute (NCI)
Recruiting - verified February 2008 -
Randomized, Phase 2 Study in Patients With Stage IIIB/IV, Non-Small Cell Lung Cancer (NSCLC) (Study P05146)
Posted: February 29th, 2008, 10:00am EST
Conditions: Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Carcinoma, Large Cell; Carcinoma, Squamous Cell
Intervention: Drug: Temozolomide
Sponsor: Schering-Plough
Not yet recruiting - verified March 2008 -
Radiation Therapy With or Without Temozolomide in Treating Patients With Anaplastic Glioma
Posted: February 28th, 2008, 10:00am EST
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Procedure: DNA methylation analysis; Procedure: adjuvant therapy; Procedure: chemotherapy; Procedure: laboratory biomarker analysis; Procedure: quality-of-life assessment; Procedure: radiation therapy
Sponsors: European Organization for Research and Treatment of Cancer; National Cancer Institute of Canada; Radiation Therapy Oncology Group; Medical Research Council
Recruiting - verified January 2008 -
Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Recovering From Lymphopenia Caused by Temozolomide
Posted: February 28th, 2008, 10:00am EST
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: cytomegalovirus pp65-specific cytotoxic T lymphocytes; Drug: imiquimod; Drug: temozolomide; Drug: therapeutic autologous dendritic cells; Drug: therapeutic autologous lymphocytes; Procedure: adoptive immunotherapy; Procedure: biopsy; Procedure: chemotherapy; Procedure: immunoenzyme technique; Procedure: immunohistochemistry staining method; Procedure: immunologic technique; Procedure: immunopotentiation therapy; Procedure: magnetic resonance imaging; Procedure: non-specific immune-modulator therapy; Procedure: non-tumor cell-derivative vaccine therapy; Procedure: peripheral blood lymphocyte therapy; Procedure: polymerase chain reaction; Procedure: quality-of-life assessment; Procedure: radiation therapy; Procedure: radioimmunotherapy; Procedure: radionuclide imaging; Procedure: reverse transcriptase-polymerase chain reaction; Procedure: single photon emission computed tomography
Sponsors: Duke University; National Cancer Institute (NCI)
Recruiting - verified February 2008 -
Daclizumab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia
Posted: February 28th, 2008, 10:00am EST
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: RNA-loaded dendritic cell vaccine; Drug: cytomegalovirus pp65-specific cytotoxic T lymphocytes; Drug: daclizumab; Drug: imiquimod; Drug: temozolomide; Drug: therapeutic autologous dendritic cells; Drug: therapeutic autologous lymphocytes; Procedure: CAM immunoaugmentative therapy; Procedure: chemotherapy; Procedure: in vitro-treated peripheral blood lymphocyte therapy; Procedure: monoclonal antibody therapy; Procedure: non-tumor cell-derivative vaccine therapy; Procedure: radionuclide imaging; Procedure: recombinant viral vaccine therapy; Procedure: single photon emission computed tomography; Procedure: stereotactic radiation therapy
Sponsors: Duke University; National Cancer Institute (NCI)
Recruiting - verified February 2008 -
Chemotherapy, Radiation Therapy, and Vaccine Therapy With or Without Daclizumab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery
Posted: February 28th, 2008, 10:00am EST
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: PEP-3-KLH conjugate vaccine; Drug: daclizumab; Drug: temozolomide; Drug: therapeutic autologous lymphocytes; Procedure: adjuvant therapy; Procedure: anti-cytokine therapy; Procedure: immunopotentiation therapy; Procedure: monoclonal antibody therapy; Procedure: non-tumor cell-derivative vaccine therapy; Procedure: peripheral blood lymphocyte therapy; Procedure: radiation therapy; Procedure: systemic chemotherapy
Sponsors: Duke University; National Cancer Institute (NCI)
Recruiting - verified February 2008 -
Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma
Posted: February 28th, 2008, 10:00am EST
Condition: Brain and Central Nervous System Tumors
Interventions: Procedure: adjuvant therapy; Procedure: radiation therapy
Sponsor: European Organization for Research and Treatment of Cancer
Recruiting - verified February 2008 -
TRICCS Childhood Cancer Survivors
Posted: February 28th, 2008, 10:00am EST
Condition: Childhood Cancer
Interventions: Behavioral: Attention Training; Behavioral: Placebo
Sponsors: Duke University; National Institutes of Health (NIH)
Active, not recruiting - verified May 2008 -
Tube Feedings in Younger Patients Receiving Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or High-Risk Solid Tumors
Posted: February 27th, 2008, 10:00am EST
Conditions: Brain and Central Nervous System Tumors; Kidney Cancer; Leukemia; Liver Cancer; Neuroblastoma; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Procedure: nutritional intervention; Procedure: therapeutic nutritional supplementation
Sponsors: Vanderbilt-Ingram Cancer Center; National Cancer Institute (NCI)
Completed - verified April 2008 -
Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients
Posted: February 27th, 2008, 10:00am EST
Condition: Primary Brain Tumor
Intervention: Drug: Innohep
Sponsors: Duke University; Pharmion
Active, not recruiting - verified February 2008 -
Computerized Cognitive Training
Posted: February 27th, 2008, 10:00am EST
Condition: Primary Brain Tumor
Intervention: Behavioral: Captain's Log Computer Program
Sponsor: Duke University
Recruiting - verified May 2008 -
Aloxi for Prevention of Acute and Delayed Chemotherapy Induced Nausea and Vomiting (CINV) in Malignant Glioma (MG) Patients Receiving Irinotecan With Bevacizumab
Posted: February 27th, 2008, 10:00am EST
Condition: Brain Cancer
Intervention: Drug: Palonosetron (Aloxi) and Dexamethasone
Sponsor: Duke University
Not yet recruiting - verified May 2008